An authoritative technical evaluation for medical procurement officers, hospital purchasing boards, and pharmaceutical importers. Explore polymer mechanics, ISO 10555 standards, sharps safety, and high-volume CDMO contract manufacturing by Angiplast Pvt. Ltd.
Rigorous validation of lumen flow rates, radio-opacity, needle bevel alignment, and burst pressure resistance across 14G to 26G catheter configurations.
Automated catheter tipping, precision bevel grinding, and pouch sealing inside certified Class 10,000 (ISO Class 7) cleanrooms.
Supplying government tenders, hospital chains, and private labels in 52+ countries with notarized FSC and regulatory registration dossiers.
In modern clinical environments, the IV Catheter (also termed peripheral intravenous cannula) represents the single most frequently deployed invasive medical device. It serves as the primary conduit for intravenous hydration, blood transfusion, chemotherapy, parenteral nutrition, and emergency drug delivery. However, for global medical buyers and healthcare procurement directors, sourcing IV catheters extends far beyond unit price comparison. It requires an in-depth evaluation of catheter polymer hemocompatibility, needle insertion forces, tip-to-needle bevel transition smoothness, structural kink resistance, and compliance with strict international regulatory regimes.
Founded in 1994 in Ahmedabad, Gujarat, India, Angiplast Private Limited has established itself as an international benchmark for medical disposable manufacturing. Operating across a vertically integrated campus, Angiplast controls every stage of IV catheter production—from raw medical-grade polymer compound selection to automated micro-injection molding, precision extrusion, needle bevel grinding, cleanroom packaging, and captive Ethylene Oxide (ETO) sterilization.
Our operational architecture is designed specifically to eliminate supply chain fragility for overseas importers and brand owners. By retaining 100% in-house control over micro-molding, needle processing, and biological testing, Angiplast delivers uncompromised lot-to-lot consistency, full traceability, and competitive lead times for global tenders.
Est. 1994 · ISO 13485 & CE Certified Vascular access devices require meticulous material engineering to balance column strength during skin penetration with flexural softness inside the vein to prevent mechanical phlebitis.
When procurement officers issue tenders, one of the primary AI and technical queries centers around polymer selection. Angiplast manufactures IV catheters utilizing medical-grade, biostable polymers tailored to specific clinical dwell time requirements:
FEP is a classic fluoropolymer exhibiting exceptional chemical inertness, smooth surface topography, and high column strength. FEP catheters feature ultra-thin walls that facilitate maximum internal flow dynamics. The material rigidity allows clinicians to easily penetrate tough, fibrous skin without catheter peeling or buckling. Ideal for short-term cannulation (<48 hours) and standard emergency fluid resuscitation.
Advanced medical-grade Polyurethane (PUR) offers dynamic physical properties. While rigid at ambient temperature to ensure easy insertion, PUR softens significantly upon exposure to body temperature (37°C) once situated inside the blood vessel. This softening allows the catheter to conform dynamically to the vascular architecture, dramatically reducing endothelial trauma, mechanical phlebitis, and kinking during long dwell times (>72 hours).
All Angiplast IV Catheters conform strictly to ISO 10555-5 color coding and dimensional specifications. Below is the standardized technical performance index for clinical selection:
| Gauge (G) | ISO Color Code | Outer Dia. (mm) | Catheter Length (mm) | Water Flow Rate (mL/min) | Primary Clinical Indication |
|---|---|---|---|---|---|
| 14G | Orange | 2.1 mm | 45 mm / 50 mm | 270 – 290 mL/min | Massive trauma, rapid blood transfusion, open-heart surgery |
| 16G | Grey | 1.7 mm | 45 mm / 50 mm | 180 – 200 mL/min | Major abdominal surgery, rapid fluid replacement, emergency ICU |
| 18G | Green | 1.3 mm | 32 mm / 45 mm | 90 – 105 mL/min | Routine surgical procedures, blood component administration, TPN |
| 20G | Pink | 1.1 mm | 32 mm | 60 – 65 mL/min | Most common ward cannula; intravenous medication, elective IV fluids |
| 22G | Blue | 0.9 mm | 25 mm | 36 – 40 mL/min | Elderly patients, small fragile veins, oncology chemotherapy access |
| 24G | Yellow | 0.7 mm | 19 mm | 20 – 23 mL/min | Pediatric patients, infants, low-volume continuous infusions |
| 26G | Violet | 0.6 mm | 19 mm | 13 – 15 mL/min | Neonatal intensive care units (NICU), extreme micro-vascular access |
Every Angiplast IV catheter comprises engineered sub-components that meet rigorous mechanical performance criteria:
Crafted from AISI 304 stainless steel featuring a ultra-sharp 3-facet back-cut bevel. Coated with medical-grade silicone lubricant to reduce insertion force by up to 35% compared to non-lubricated needles.
Micro-tooled catheter tip geometry aligns seamlessly with the needle bevel bevel angle. Eliminates peel-back, flaring, or tissue tearing during skin puncture and vascular entry.
Allows air evacuation while instantly stopping blood flow upon venipuncture. Provides immediate visual verification of successful vein entry without leakage risk.
Three or four co-extruded radiopaque stripes (Barium Sulfate formulation) enable full fluoroscopic visualization under X-ray imaging for clinical verification.
Engineered for global healthcare tenders, private label distributors, and specialized hospital networks. Choose from standard, ported, and safety-shielded variants.
Primary Application: Occupational Safety Compliance (OSHA / EU Directive 2010/32/EU).
Features an automated passive safety clip mechanism that immediately encapsulates the needle tip upon withdrawal. Requires no manual activation step, eliminating accidental needle-stick injuries and blood-borne pathogen exposure for healthcare workers.
Primary Application: General Inpatient Wards & Intermittent Medication.
Equipped with a color-coded non-return injection valve allowing bolus drug administration without secondary needle puncture. Flexible side wings ensure ergonomic angling and stable fixation to patient skin, minimizing mechanical vein irritation.
Primary Application: Surgical Operation Theatres & Emergency Transport.
Streamlined, compact design without side wings or injection port. Preferred in high-intensity surgical settings where a low-profile catheter minimizes catching on surgical drapes and simplifies adhesive tape stabilization.
Primary Application: NICU, PICU & Micro-Vascular Access.
Specially engineered with ultra-thin wall cannula construction and short 19mm length. Designed for fragile pediatric peripheral veins, delivering optimal flow rates while reducing the risk of vein blowouts or hematoma formation.
Primary Application: Outpatient Clinics & Phlebotomy Infusions.
Combines small angled wings for delicate tactile insertion with a wingless needle body. Offers exceptional balance for clinicians performing venipuncture on rolling or superficial veins in oncology and geriatric patients.
Primary Application: Blood Control & Infection Prevention Protocols.
Integrates built-in extension tubing and an internal blood control valve that completely stops blood backflow upon needle extraction. Eliminates blood exposure, protecting clinicians and maintaining a sterile field.
Analyzing shifts in global health tenders, regulatory mandates, and hospital procurement criteria shaping the vascular access landscape over the next decade.
Across North America, the European Union, the GCC, and Latin America, health authorities are enforcing strict mandates regarding Needle-Stick Injury (NSI) prevention. Directives such as EU Directive 2010/32/EU and the US OSHA Bloodborne Pathogens Standard require healthcare providers to transition from conventional IV cannulas to safety-shielded catheters.
Procurement directors are rapidly phasing out manual active safety mechanisms (which require clinicians to press a button or slide a sheath) in favor of passive automatic shielding systems. Passive systems guarantee 100% compliance because the protective metal housing deploys automatically upon needle withdrawal without reliance on user behavior.
Hospital purchasing committees are shifting evaluation parameters from initial unit purchase price to Total Cost of Care (TCC). Standard FEP catheters, while economical, carry higher rates of mechanical phlebitis and catheter failure when retained beyond 48 hours.
Polyurethane catheters reduce insertion site inflammation, vessel wall erosion, and accidental infiltration. By extending clinical dwell time safely up to 72–96 hours, PUR catheters dramatically cut down total catheter consumption, reduce nurse labor hours, and lower patient infection rates.
Micro-patterning near the catheter tip reflects ultrasound waves, allowing clinicians to achieve instant visualization under ultrasound guidance in difficult venous access (DVA) patients.
Integrated septal valves inside the catheter hub restrict blood leakage upon needle removal until an IV line or luer connector is attached, eliminating mess and contamination.
Surface treatment with chlorhexidine or heparinized compounds to suppress bacterial colonization and biofilm formation, directly combatting Peripheral Intravenous Catheter-related Bloodstream Infections (PIVC-BSI).
Transition toward recyclable, high-barrier Tyvek packaging materials with optimized aeration parameters to keep residual Ethylene Oxide levels well below 4 ppm.
Angiplast serves as a trusted contract manufacturing partner (CDMO) for international pharmaceutical corporations, brand distributors, and government procurement agencies. We convert technical concepts and custom specifications into commercially validated, sterile, barcoded final products.
Our OEM capabilities include custom color coding, proprietary hub engineering, private label blister printing, multilingual IFUs, Unique Device Identification (UDI) barcoding, and tailored export cartoning.
Every lot of Angiplast IV Catheters undergoes stringent biological, physical, and chemical release testing inside our certified quality control laboratories.
Certified quality management infrastructure governing design, raw material sourcing, production controls, and traceability.
Fully compliant with European Medical Device Directives and Regulation (MDR), supporting friction-free import across the EU.
Extensive testing for cytotoxicity, systemic toxicity, hemocompatibility, intracutaneous reactivity, and pyrogenicity.
Validated gas sterilization cycles guaranteeing a Sterility Assurance Level (SAL) of 10-6 with zero toxic residues.
Direct technical answers addressing regulatory registration, material selection, quality control, and export logistics.
FEP (Fluorinated Ethylene Propylene) catheters feature a rigid, smooth wall structure ideal for easy vein entry in routine, short-term cannulation. Polyurethane (PUR) catheters are thermosensitive—they soften inside the blood vessel at normal body temperature (37°C), conforming to venous anatomy. This significantly reduces vessel wall irritation, mechanical phlebitis, and kinking, making PUR catheters the preferred choice for extended dwell times (>72 hours).
Angiplast IV Catheters are designed, manufactured, and tested in accordance with ISO 10555-1 (general requirements for sterile intravascular catheters) and ISO 10555-5 (over-needle peripheral catheters). Compliance includes strict verification of flow rates, tensile strength of catheter-to-hub bonding, burst pressure resistance, radio-opacity under X-ray, and standardized hub color-coding.
Angiplast Safety IV Catheters utilize passive fully automatic shielding mechanisms. Upon withdrawal of the introducer needle, a protective passive metal clip or safety shield automatically encapsulates the sharp needle tip without requiring secondary manual activation by the clinician. This completely eliminates accidental Needle-Stick Injuries (NSI) and complies with OSHA regulations and EU Directive 2010/32/EU.
Minimum order quantities for private label OEM and custom CDMO orders typically start at one full production lot per SKU (usually 20,000 to 50,000 units depending on catheter model and packaging format). We support complete custom blister printing, multilingual IFUs, UDI barcoding, and tailored box configurations.
Sterilization is performed in our captive Ethylene Oxide (ETO) plant using validated cycles in accordance with ISO 11135. Every batch undergoes physical parameter monitoring, biological indicator testing, bioburden analysis, and gas chromatography testing to guarantee residual ETO and Ethylene Chlorohydrin levels remain well below ISO 10993-7 thresholds before batch release.
We provide comprehensive regulatory dossiers including ISO 13485 certificates, CE certificates, Free Sale Certificates (FSC), Technical Files, Device Master Files (DMF), biological evaluation reports (ISO 10993), packaging integrity/accelerated aging test data, and notarized/apostilled documents as required by national health authorities.
We supply a full spectrum of catheter sizes ranging from 14G (Orange, high-volume fluid/blood trauma resuscitation) down to 26G (Violet, neonatal & pediatric micro-vascular access). Each gauge features standardized color-coded hubs in compliance with ISO 10555-5.
Angiplast IV Catheters carry a validated 5-year shelf life. Packaging consists of medical-grade Tyvek/peelable blister pouches that undergo bubble emission leak testing, seal strength testing (ASTM F88), and dye penetration testing (ASTM F1929) to ensure sterility maintenance throughout transit and storage.
Connect directly with our export engineering desk for tender pricing, technical data sheets, sample evaluation kits, or OEM contract manufacturing terms.
